期刊文献+

β-catenin基因沉默对肝癌干细胞干性转录因子的影响

Effects of beta-catenin gene silencing on stemness transcription factors in hepatocellular carcinoma stem cells
下载PDF
导出
摘要 背景:肝癌干细胞是导致癌细胞形成、更新和增殖的原因,寻找针对肝癌干细胞治疗的关键靶点,并进一步拓展肝癌综合治疗手段是重要研究课题。目的:观察β-catenin基因沉默后CD133+HepG2细胞干性转录因子变化,探讨β-catenin调控肝癌干细胞干性的作用机制。方法:采用免疫磁珠筛选CD133+HepG2细胞,然后经干细胞培养基诱导、扩增方案获得CD133+HepG2肝癌干细胞,流式细胞术鉴定CD133+HepG2细胞阳性率,RNA干扰技术构建沉默β-catenin基因表达的β-catenin-shRNA慢病毒质粒,转染CD133+HepG2肝癌干细胞72 h,荧光标记并评估转染效率。确认β-catenin沉默后,平板克隆形成实验观察CD133+HepG2肝癌干细胞增殖情况,流式细胞术检测CD133+HepG2肝癌干细胞的细胞周期,qRT-PCR和Western blot检测干性转录因子SOX2,NANOG,OCT4的mRNA及蛋白表达水平。结果与结论:与空白对照组和病毒空载组相比,病毒干扰组的细胞克隆形成能力明显降低,G_(0)/G_(1)期细胞百分比明显增多,S期和G_(2)/M期细胞百分比降低,NANOG、SOX2、OCT4的蛋白和mRNA表达水平明显降低(P<0.05),提示下调β-catenin表达可能对抑制肝癌干细胞的干性水平具有潜在作用。 BACKGROUND:Hepatocellular carcinoma stem cell is responsible for the formation,renewal and proliferation of cancer cells.It is a major topic to find key targets for hepatocellular carcinoma stem cell therapy and to further expand comprehensive treatment means for liver cancer.OBJECTIVE:To observe changes of stemness transcription factors afterβ-catenin gene silencing on CD133+HepG2 cells,and investigate the action mechanism ofβ-catenin regulating stemness of hepatocellular carcinoma stem cells.METHODS:After CD133+HepG2 hepatocellular carcinoma stem cells were screened by magnetic activated cell sorting,these cells were induced and cultured in stem cell culture medium.Positive rate of CD133+HepG2 hepatocellular carcinoma stem cells was identified by flow cytometry.β-Catenin shRNA lentiviral plasmid was constructed to inhibitβ-catenin expression by RNA interference.After transfected CD133+HepG2 hepatocellular carcinoma stem cells for 72 hours,plasmid was labeled with fluorescence,which evaluated transfection efficiency.Afterβ-catenin silencing was confirmed,CD133+HepG2 hepatocellular carcinoma stem cell proliferation was measured by plate clone formation assay.CD133+HepG2 hepatocellular carcinoma stem cell cycle was detected by flow cytometry.RT-PCR and western blot assay were used to detect the mRNA and protein expression of stemness transcription factors SOX2,NANOG and OCT4.RESULTS AND CONCLUSION:Compared with blank control group and virus-free group,clone formation ability was decreased in virus-blockade group.Percentage of G_(0)/G_(1) phase cells increased significantly,while that of S phase cells and G_(2)/M phase cells decreased.Protein and mRNA expression of NANOG,SOX2 and OCT4 was significantly decreased in virus-blockade group(P<0.05).It is indicated that down-regulation ofβ-catenin expression may have a potential effect on suppressing the stemness of hepatocellular carcinoma stem cells.
作者 孙华 覃艳春 荣震 李祖隆 蒋锐沅 钟晓婷 莫春梅 Sun Hua;Qin Yanchun;Rong Zhen;Li Zulong;Jiang Ruiyuan;Zhong Xiaoting;Mo Chunmei(Bao’an Authentic TCM Therapy Hospital,Shenzhen 518101,Guangdong Province,China;University of Traditional Chinese Medicine,Nanning 530200,Guangxi Zhuang Autonomous Region,China)
出处 《中国组织工程研究》 CAS 北大核心 2023年第15期2297-2303,共7页 Chinese Journal of Tissue Engineering Research
基金 国家传染病防治重大专项课题(2018ZX10303502-001,2018ZX10303502-002),项目参与人:荣震、莫春梅 国家自然科学基金项目(81760850),项目负责人:莫春梅。
关键词 肝癌干细胞 干细胞转录因子 Β-CATENIN RNA干扰 CD133 HEPG2 hepatocellular carcinoma stem cell stem cell transcription factor β-catenin RNA interference CD133 HepG2
  • 相关文献

参考文献4

二级参考文献88

  • 1Psyrri A,Arkadopoulos N,Vassilakopoulou M ,et al. Path- ways and targets in hepatocellular carcinoma[J]. Expert Rev Anticancer Ther,2012,12(10) : 1347-1357.
  • 2Songdo S, Bae SH. Changes of guidelines diagnosing hepa- tocellular carcinoma during the last ten-year period [J]. Clin Mol Hepatol, 2012,18(3) : 258-267.
  • 3Castillo SD,Sanchez M. The SOX family of genes in cancer development:biological relevance and opportunities for therapy[J]. Expert Opin Ther Targets, 2012,16(9) : 903-919.
  • 4Sarkar A,Hochedlinger K. The sox family of transcription factors : versatile regulators of stem and progenitor cell fate [J]. Cell Stem Cell,2013,12(1): 15-30.
  • 5Dong C,Wilhelm D,Koopman P. Sox genes and cancer[J]. Cytogenet Genome Res, 2004,105(2-4) :442-447.
  • 6Huang P,Qiu J, Li B,et al. Role of Sox2 and Oct4 in pre- dicting survival of hepatocellular carcinoma patients after hepatectomy[J]. Clin Biochem, 2011,44(8-9) : 582-589.
  • 7Pei D. Regulation of pluripotency and reprogramming by tran- scription factors{J} J Biol Chem,2009,284(6):3365-3369.
  • 8Gen Y,Yasui K,Zen Y,et al. SOX2 identified as a target gene for the amplification at 3q26 that is frequently de- tected in esophageal squamous cell carcinoma[J- Cancer Gene Cytogenet, 2010,202(2) : 82-93.
  • 9Neumann J,Bahr F,Horst D,et al. SOX2 expression cor- relates with lymph-node metastases and distant spread in right-sided colon cancer[J]. BMC Cancer, 2011,11 : 518.
  • 10Sasaki H,Yokota K,Hikosaka Y,et al. Increased Sox2 copy number in lung squamous cell carcinomas[J]. Exp Ther Med, 2012,3(1) : 44-48.

共引文献1227

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部